| Gene symbol | ERBB2 | Synonyms | CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | erb-b2 receptor tyrosine kinase 2 | ||||
| GTO ID | GTC1350 |
| Trial ID | NCT01109095 |
| Disease | Brain Glioblastoma Multiforme |
| Altered gene | HER2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | HER2 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM |
| Year | 2010 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-24487 - HERT GBM |
| Cohort 1 | |||||||||
|
|||||||||